BioCentury | Sep 29, 2008
Finance

Ebb & Flow

...investors MPM Capital; Alloy Ventures; GBS Venture Partners; Sofinnova Ventures; Singapore BioInnovations; 5AM Ventures; and Lotus BioScience...
BioCentury | Sep 24, 2008
Financial News

KaloBios raises $20 million

...investors MPM Capital; Alloy Ventures; GBS Venture Partners; Sofinnova Ventures; Singapore BioInnovations; 5AM Ventures; and Lotus BioScience...
BioCentury | Jul 30, 2007
Finance

Ebb & Flow

...new investor. Existing investors MPM Capital; Sofinnova Ventures; Alloy Ventures; 5AM Ventures; Singapore BioInnovations; and Lotus BioScience...
BioCentury | Jul 23, 2007
Financial News

KaloBios raises $20 million

...Lehman Brothers. Existing investors MPM Capital; Sofinnova Ventures; Alloy Ventures; 5AM Ventures; Singapore BioInnovations; and Lotus BioScience...
BioCentury | May 7, 2007
Finance

Ebb & Flow

Five executives at MedImmune (MEDI) will be receiving more than $280 million when the $15.6 billion acquisition by AstraZeneca (LSE:AZN; AZN) closes. By comparison, the biotech sector raised a total of $566 million last week,...
BioCentury | May 4, 2007
Financial News

Aveo raises $53 million

Aveo ( Cambridge , Mass.) raised $53 million in a series D round. New investors Biogen Idec (BIIB); Bessemer Venture Partners; Merlin BioMed Group; Mitsubishi UFJ; and Vatera Holdings joined existing investors Highland Capital; Venrock Associates; MPM...
BioCentury | Aug 15, 2005
Finance

Ebb & Flow

...round. Investors included Chicago Growth Partners; Enterprise Partners; Alliance Technology Ventures; Tullis-Dickerson; U.S. Trust; and Lotus BioScience...
BioCentury | Aug 11, 2005
Financial News

Genoptix raises $17.3 million

...round. Investors included Chicago Growth Partners; Enterprise Partners; Alliance Technology Ventures; Tullis-Dickerson; U.S. Trust; and Lotus BioScience...
BioCentury | Mar 21, 2005
Finance

Ebb & Flow

...and KB002 is in development for rheumatoid arthritis (RA). Investors were MPM Capital; GBS Venture; Lotus BioScience...
BioCentury | Mar 17, 2005
Financial News

KaloBios raises $20 million

...in a series B round led by MPM Capital and GBS Venture. Other investors included Lotus BioScience...
Items per page:
1 - 10 of 38
BioCentury | Sep 29, 2008
Finance

Ebb & Flow

...investors MPM Capital; Alloy Ventures; GBS Venture Partners; Sofinnova Ventures; Singapore BioInnovations; 5AM Ventures; and Lotus BioScience...
BioCentury | Sep 24, 2008
Financial News

KaloBios raises $20 million

...investors MPM Capital; Alloy Ventures; GBS Venture Partners; Sofinnova Ventures; Singapore BioInnovations; 5AM Ventures; and Lotus BioScience...
BioCentury | Jul 30, 2007
Finance

Ebb & Flow

...new investor. Existing investors MPM Capital; Sofinnova Ventures; Alloy Ventures; 5AM Ventures; Singapore BioInnovations; and Lotus BioScience...
BioCentury | Jul 23, 2007
Financial News

KaloBios raises $20 million

...Lehman Brothers. Existing investors MPM Capital; Sofinnova Ventures; Alloy Ventures; 5AM Ventures; Singapore BioInnovations; and Lotus BioScience...
BioCentury | May 7, 2007
Finance

Ebb & Flow

Five executives at MedImmune (MEDI) will be receiving more than $280 million when the $15.6 billion acquisition by AstraZeneca (LSE:AZN; AZN) closes. By comparison, the biotech sector raised a total of $566 million last week,...
BioCentury | May 4, 2007
Financial News

Aveo raises $53 million

Aveo ( Cambridge , Mass.) raised $53 million in a series D round. New investors Biogen Idec (BIIB); Bessemer Venture Partners; Merlin BioMed Group; Mitsubishi UFJ; and Vatera Holdings joined existing investors Highland Capital; Venrock Associates; MPM...
BioCentury | Aug 15, 2005
Finance

Ebb & Flow

...round. Investors included Chicago Growth Partners; Enterprise Partners; Alliance Technology Ventures; Tullis-Dickerson; U.S. Trust; and Lotus BioScience...
BioCentury | Aug 11, 2005
Financial News

Genoptix raises $17.3 million

...round. Investors included Chicago Growth Partners; Enterprise Partners; Alliance Technology Ventures; Tullis-Dickerson; U.S. Trust; and Lotus BioScience...
BioCentury | Mar 21, 2005
Finance

Ebb & Flow

...and KB002 is in development for rheumatoid arthritis (RA). Investors were MPM Capital; GBS Venture; Lotus BioScience...
BioCentury | Mar 17, 2005
Financial News

KaloBios raises $20 million

...in a series B round led by MPM Capital and GBS Venture. Other investors included Lotus BioScience...
Items per page:
1 - 10 of 38